Jianmin Pharmaceutical Group Co.,Ltd. (SHSE: 600976)
Health Care · Pharmaceuticals · CN
CN¥27.54
-5.59% today · -33.7% 1Y
Jianmin Pharmaceutical Group Co.,Ltd. (SHSE: 600976) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $628.44M and employs 2,257 people.
Over the last twelve months the share price has lost 33.7%, trading between 24.68 and 43.72.
Tweenvest scores Jianmin Pharmaceutical Group Co.,Ltd. across four factors: quality 71/100, value 84/100, growth 56/100, dividend 51/100. Its strongest factor is value.
600976 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $628.44M
- Revenue (TTM)
- $467.62M
- P/E
- 13.23
- EPS
- 2.08
- Dividend yield
- 3.27%
- Beta (5Y)
- 0.08
- 52-week high
- CN¥43.72
- 52-week low
- CN¥24.68
- Avg volume (3M)
- —
- Shares outstanding
- 153.40M
- Employees
- 2,257
- Next earnings
- —
About Jianmin Pharmaceutical Group Co.,Ltd.
Jianmin Pharmaceutical Group Co.,Ltd. operates within China, focusing on the production and distribution of traditional Chinese medicines. The company's product line features pediatric pharmaceuticals, prominently sold under its Jianmin and Longmu brand names. In addition to these offerings, Jianmin provides a range of over-the-counter (OTC) drugs, various medical and health products, and consultation services. The firm's main corporate offices are located in Wuhan, China.
- ISIN
- CNE000001HB7
- Founded
- 1637
- Listed since
- Apr 19, 2004
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.